https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-11-20 / J. Gastroenterol. 2010 Apr;45(4):451-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-11-20 / J. Gastroenterol. 2010 Apr;45(4):451-82009-11-20 00:00:002019-02-15 09:02:54Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-11-04 / Vaccine 2009 Dec;28(2):542-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-11-04 / Vaccine 2009 Dec;28(2):542-72009-11-04 00:00:002019-02-15 08:44:10Comparison of monocyte-derived dendritic cells from colorectal cancer patients, non-small-cell-lung-cancer patients and healthy donors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1964-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1964-62009-11-01 00:00:002009-11-01 00:00:00[Dendritic cell vaccine for intrahepatic cholangio cellular carcinoma–a study of relationship between immuno-reaction and clinical outcome]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1988-90
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1988-902009-11-01 00:00:002009-11-01 00:00:00[The case of tumor escape mechanism by changing their tumor-associated antigens]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-11-01 / Expert Rev Anticancer Ther 2009 Nov;9(11):1577-82
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-11-01 / Expert Rev Anticancer Ther 2009 Nov;9(11):1577-822009-11-01 00:00:002019-02-15 08:48:32Heat-shock protein vaccines as active immunotherapy against human gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-11-01 / Radiother Oncol 2009 Nov;93(2):358-63
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-11-01 / Radiother Oncol 2009 Nov;93(2):358-632009-11-01 00:00:002019-02-15 09:17:31Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-11-01 / Scand. J. Immunol. 2009 Nov;70(5):481-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-11-01 / Scand. J. Immunol. 2009 Nov;70(5):481-92009-11-01 00:00:002019-02-15 09:16:49Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate
